Study Evaluating Rapamune in Patients After Kidney Transplantation

Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

NCT00086346 ·Status: TERMINATED ·Phase: PHASE3

Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries

NCT00195195 ·Status: COMPLETED

Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation

NCT00123331 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

NCT00811915 ·Status: TERMINATED ·Phase: PHASE3

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

NCT00519116 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

NCT00518271 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

NCT00044720 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

NCT00257387 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

NCT00306397 ·Status: COMPLETED ·Phase: PHASE4

Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

NCT00252655 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of Sirolimus in Combination With Tacrolimus

NCT00141804 ·Status: UNKNOWN ·Phase: PHASE3

Study Evaluating Sirolimus in Kidney Transplant Recipients.

NCT00167947 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

NCT00273871 ·Status: COMPLETED ·Phase: PHASE3

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

NCT02057484 ·Status: COMPLETED

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

NCT00866879 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

NCT00470665 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

NCT00428064 ·Status: COMPLETED ·Phase: PHASE3

Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients

NCT00204321 ·Status: COMPLETED ·Phase: PHASE4

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

NCT00768729 ·Status: COMPLETED ·Phase: PHASE1

Calcineurin Free Immunosuppression in Renal Transplant Recipients

NCT00812123 ·Status: COMPLETED ·Phase: PHASE4

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

NCT02311010 ·Status: UNKNOWN ·Phase: PHASE4

A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients

NCT01742676 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

NCT01742624 ·Status: COMPLETED ·Phase: PHASE4

Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients

NCT01236378 ·Status: COMPLETED ·Phase: PHASE1

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

NCT00275535 ·Status: COMPLETED ·Phase: PHASE4